All In Biotech

Drug Trial Radar · NCT01241318

Zambia Chlorhexidine Application Trial

Impact of Chlorhexidine Cord Cleansing for Prevention of Neonatal Mortality in Zambia

Last checked: Nov 19, 2026Latest source record: Aug 31, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 77,535 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

77,535

Actual

Start

Feb 2011

Primary completion

Sep 2013

Study completion Sep 2013

Sponsor

Lead sponsor
Boston UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bill and Melinda Gates Foundation; Ministry of Health, Zambia; Zambia Center for Applied Health Research and Development
First posted
Nov 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 15 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This will be a cluster-randomized controlled trial to assess whether washing the umbilical cord with a disinfectant (4% chlorhexidine) helps to reduce neonatal deaths in Zambia when compared to the current standard of care, dry cord care.

Conditions

  • Sepsis

Interventions

  • Chlorhexidine gluconate (4%)Drug

    Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

  • Dry cord careProcedure

    Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause Neonatal MortalityTime frame: 28 days post-partum
  2. All-cause Neonatal Mortality Among Newborns Who Survived at Least First Day of LifeTime frame: 28 days post-partum

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Facilities throughout Southern Province

    Choma, Southern Province, Zambia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.